Background/aim: To assess the perioperative outcomes of cholecystectomy in cytoreductive procedures for epithelial ovarian cancer (EOC).
Patients And Methods: Prospectively collected perioperative data of patients that underwent cytoreduction for advanced EOC, between 2014 and 2018, were analysed. Patients were divided in two groups on the basis of whether cholecystectomy was performed.
Results: A total of 144 patients with stage IIIC/IV EOC were included. Cholecystectomy was performed in 22 (15.3%) patients. Those who underwent cholecystectomy more likely required diaphragmatic peritonectomy, splenectomy, lesser omentectomy, excision of disease from the porta hepatis and liver's capsule (p<0.001). There was no difference in the cytoreductive outcomes (complete or optimal) and the rate of grade 3-5 complications between the two groups (p=0.10 & p=0.06, respectively). No direct complications related to cholecystectomy were observed.
Conclusion: A significant percentage of patients with advanced EOC require cholecystectomy. Gynecologic oncologists should embrace the opportunity to develop advanced surgical skills including cholecystectomy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.21873/anticanres.14200 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Laparoscopic peritoneal mucinous cystadenoma debulking: A case report.
Medicine (Baltimore)
January 2025
Department of General Surgery, Nujiang Prefecture People's Hospital, Yunnan, Nujiang, China.
Rationale: Peritoneal mucinous cystadenoma is rare in the clinic, lacks specific clinical manifestations, tumor markers, and imaging features, and is easily misdiagnosed and missed. Clinical practitioners should maintain a high level of vigilance. Here, we report a case of laparoscopic peritoneal mucinous cystadenoma stripping to improve our understanding of the disease.
View Article and Find Full Text PDFASO Author Reflections: Systematic Cholecystectomy and Other Issues During Cytoreductive Surgery and Intraperitoneal Chemotherapy: We Need To Keep Talking.
Ann Surg Oncol
October 2024
Hospital Clínico Universitario Virgen de la Arrixaca, Servicio de Cirugía General y del Aparato Digestivo, El Palmar, Spain.
Systematic Cholecystectomy During Cytoreductive Surgery Plus HIPEC: A Critical Analysis of an Empirical Tradition.
Ann Surg Oncol
October 2024
Departamento de Cirugía, Unidad de Cirugía Oncológica Peritoneal, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Article Synopsis
- This study critically assesses the necessity of systematic cholecystectomy (gallbladder removal) during cytoreductive surgery (CRS) and hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) for patients with peritoneal carcinomatosis, using long-term follow-up data.* -
- An analysis of 443 patients treated between 2008 and 2022 found that while some had gallbladder issues and underwent cholecystectomy, the majority (373) did not, with only a small number developing gallstone-related complications post-surgery.* -
- The conclusion suggests that while cholecystectomy is generally safe, it may not be necessary as a standard procedure during
Prophylactic Cholecystectomy is Safe in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy.
Am Surg
June 2024
Section of Surgical Sciences, Division of Surgical Oncology and Endocrine Surgery, Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Background: While cholecystectomy is one of the most common operations performed in the United States, there is a continued debate regarding its prophylactic role in elective surgery. Particularly among patients with peritoneal carcinomatosis who undergo cytoreduction surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC), further abdominal operations may pose increasing morbidity due to intraabdominal adhesions and potential recurrence. This bi-institutional retrospective study aims to assess postoperative morbidity associated with prophylactic cholecystectomy at the time of CRS-HIPEC.
View Article and Find Full Text PDFCholecystectomy at the time of open cytoreductive surgery for ovarian cancer.
Gynecol Oncol Rep
June 2024
Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
Introduction: We sought to demonstrate a method of performing open cholecystectomy at the time of cytoreductive surgery for ovarian cancer.
Case/methods: In this surgical film, we present the case of a 78-year-old woman with metastatic high-grade serous ovarian cancer who underwent primary cytoreductive surgery at Memorial Sloan Kettering Cancer Center (New York, NY). The surgery was recorded via video, and important steps of performing a cholecystectomy were highlighted.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!